Ramucirumab in metastatic renal cell carcinoma: The sex, race, and age issues

E-ISSN： 1097-0142|120|15|2379-2379

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.15, 2014-08, pp. : 2379-2379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1604-1607

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1647-1655

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urologic Approaches to Metastatic Renal Cell Carcinoma

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 122-126

Karger

Access to resources Recommend Favorite

Metastatectomy prior to Immunochemotherapy for Metastatic Renal Cell Carcinoma

Urologia Internationalis, Vol. 76, Iss. 3, 2006-04 ,pp. : 256-263

Karger

Access to resources Recommend Favorite

Patterns of care for metastatic renal cell carcinoma in Australia

BJU INTERNATIONAL, Vol. 116, Iss. S3, 2015-10 ,pp. : 36-41

John Wiley & Sons Inc

Access to resources Recommend Favorite